Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

A second study reported the twice-a-year injections lowered the HIV infection rate by 96% in groups of cisgender men and gender-diverse people in the U.S., Argentina, Brazil, Mexico, Peru, South ...

Membrane fusion, one of the most fundamental processes in life, occurs when two separate lipid membranes merge into a single continuous bilayer. Membrane fusion is essential for the entry of ...

The cuts will shutter two major HIV vaccine research efforts that were first funded by the NIH in 2012 at the Duke Human Vaccine Institute and the Scripps Research Institute, multiple scientists said.

Early symptoms of HIV infection, often occurring 2-4 weeks after exposure, are often mistaken for the flu or other common illnesses. These symptoms include fever, rash, sore throat, swollen lymph ...

In people who are HIV-negative, PEP prevents the virus from causing infection and spreading. But you must start PEP within 72 hours (3 days) of when you’re exposed to the virus for it to work.

Deep cuts to HIV research could halt decades of progress, scientists say The Trump administration has shut down government offices devoted to HIV and ended hundreds of millions of dollars in ...

The NIH has eliminated funding for dozens of HIV-related research grants, according to a US Department of Health and Human Services database that was updated last week, halting studies and ...

Human immunodeficiency virus (HIV) is a type of virus that preferentially targets white blood cells called CD4 T-cells. By killing more and more of these cells, the body's immune defenses are weakened ...

Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus ...